NGM BiopharmaceuticalsNGM
13F holders, Q1 2024 (March 31)75holders
5famous investors
$1.59avg. 13F price*
At the end of Q1 2024, 75 institutions reported holding NGM Biopharmaceuticals Inc. (NGM) in their 13F filings. The largest holders were Column Group LLC ($28.8M), BlackRock Inc. ($4.8M) and Vanguard Group Inc. ($3.7M). 5 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Paul Tudor Jones (0.0% of Tudor Investment Corporation's portfolio).
- Company
- NGM Biopharmaceuticals Inc.
- CUSIP
- 62921N105
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 15 | $4.2M |
| Exits | 23 | $5.3M |
Ownership 75 holders
| Column Group LLC | 17.96% | No change | 18,136,735 | $28.8M |
| BlackRock Inc. | 0.00% | Reduce -5.5% | 3,004,210 | $4.8M |
| Vanguard Group Inc. | 0.00% | Reduce -16.1% | 2,324,392 | $3.7M |
| StepStone Group LP | 0.53% | No change | 1,573,357 | $2.5M |
| Euclidean Capital LLC | 0.20% | No change | 992,168 | $1.6M |
| Geode Capital Management, LLC | 0.00% | Add +6.8% | 983,836 | $1.6M |
| Trium Capital LLP | 0.58% | New | 977,965 | $1.6M |
| State Street Corp. | 0.00% | Add +0.1% | 823,111 | $1.3M |
| ADAR1 Capital Management, LLC | 0.35% | New | 816,581 | $1.3M |
| Renaissance Technologies | 0.00% | Reduce -19.2% | 611,300 | $972K |
| Two Sigma Advisers, LP | 0.00% | Reduce -13.8% | 505,900 | $804K |
| Northern Trust Corp. | 0.00% | Add +10.5% | 372,733 | $593K |
| Balyasny Asset Management L.P. | 0.00% | New | 360,599 | $573K |
| Citadel Advisors | 0.00% | Add +374.1% | 342,195 | $544K |
| Charles Schwab Investment Management Inc. | 0.00% | Add +2.1% | 284,649 | $453K |
| Goldman Sachs Group Inc. | 0.00% | Add +89.1% | 209,298 | $333K |
| Exchange Traded Concepts, LLC | 0.01% | Add +74.0% | 186,232 | $296K |
| Natixis | 0.00% | New | 181,366 | $288K |
| BNP Paribas Financial Markets | 0.00% | Reduce -22.3% | 171,397 | $273K |
| Morgan Stanley | 0.00% | Reduce -3.1% | 155,462 | $247K |
| Dimensional Fund Advisors LP | 0.00% | No change | 154,456 | $246K |
| Bank of New York Mellon Corp | 0.00% | Reduce -4.2% | 133,225 | $212K |
| Citigroup Inc. | 0.00% | Add +1354.8% | 107,481 | $171K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | New | 98,037 | $156K |
| Nuveen Asset Management, LLC | 0.00% | Reduce -84.9% | 94,178 | $150K |
| Hennion & Walsh Asset Management, Inc. | 0.01% | Add +7.1% | 70,636 | $112K |
| Rhumbline Advisers | 0.00% | Add +2.3% | 66,344 | $105K |
| Millennium Management | 0.00% | Reduce -94.8% | 66,180 | $105K |
| Alliancebernstein L.P. | 0.00% | No change | 64,310 | $102K |
| Mirae Asset Global Investments Co., Ltd. | 0.00% | New | 21,169 | $81K |
| Virtu Financial LLC | 0.01% | New | 48,708 | $77K |
| Jane Street Group, LLC | 0.00% | Reduce -18.2% | 48,238 | $77K |
| STRS Ohio | 0.00% | Reduce -5.9% | 46,000 | $73K |
| UBS Group AG | 0.00% | Reduce -2.9% | 45,436 | $72K |
| State Board of Administration of Florida Retirement System | 0.00% | Add +38.2% | 15,654 | $64K |
| FMR LLC | 0.00% | Reduce -48.0% | 35,061 | $56K |
| Gsa Capital Partners LLP | 0.00% | Reduce -90.0% | 33,529 | $53K |
| Barclays PLC | 0.00% | Reduce -66.8% | 30,260 | $48K |
| Diker Management LLC | 0.04% | New | 29,996 | $48K |
| Two Sigma Investments, LP | 0.00% | Reduce -94.3% | 27,800 | $44K |
| Clarius Group, LLC | 0.00% | Add +1.1% | 26,912 | $43K |
| XTX Topco Ltd | 0.01% | Reduce -10.2% | 26,022 | $41K |
| Bank of America Corp. | 0.00% | Reduce -54.9% | 25,721 | $41K |
| Tudor Investment Corporation | 0.00% | No change | 25,147 | $40K |
| Carson Advisory Inc. | 0.03% | No change | 22,550 | $36K |
| Engineers Gate Manager LP | 0.00% | No change | 22,269 | $35K |
| American International Group, Inc. | 0.00% | Reduce -0.8% | 21,480 | $34K |
| Principal Financial Group Inc. | 0.00% | Add +4.1% | 19,796 | $31K |
| Oxford Asset Management LLP | 0.03% | New | 19,458 | $31K |
| Jasper Ridge Partners, L.P. | 0.00% | No change | 19,250 | $31K |
| JPMorgan Chase & Co. | 0.00% | Reduce -34.5% | 18,500 | $29K |
| AQR Capital Management | 0.00% | New | 16,963 | $27K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 15,910 | $25K |
| Wells Fargo & Company | 0.00% | Add +10.6% | 15,407 | $24K |
| SG Americas Securities, LLC | 0.00% | Reduce -36.5% | 15,074 | $24K |
| Invesco Ltd. | 0.00% | Reduce -5.6% | 12,936 | $21K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | New | 11,644 | $19K |
| T. Rowe Price Associates Inc. | 0.00% | Add +7.8% | 10,869 | $18K |
| New York State Common Retirement Fund | 0.00% | Reduce -0.2% | 10,252 | $16K |
| California State Teachers Retirement System | 0.00% | Reduce -38.9% | 4,381 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -68.7% | 3,654 | $6K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 3,117 | $5K |
| Legal & General Group Plc | 0.00% | No change | 3,029 | $5K |
| Cutler Group LLC / CA | 0.00% | No change | 3,100 | $4K |
| Amalgamated Bank | 0.00% | Reduce -62.9% | 1,373 | $2K |
| Royal Bank of Canada | 0.00% | Reduce -91.5% | 1,095 | $2K |
| Group One Trading LLC | 0.00% | No change | 1,052 | $2K |
| Capital Advisors, Ltd. LLC | 0.00% | New | 777 | $1K |
| GAMMA Investing LLC | 0.00% | No change | 346 | $550 |
| Farther Finance Advisors, LLC | 0.00% | New | 96 | $150 |
| Nisa Investment Advisors, LLC | 0.00% | No change | 75 | $119 |
| Avior Wealth Management, LLC | 0.00% | New | 7 | $11 |
| Simplex Trading, LLC | 0.00% | Reduce -81.0% | 28 | $0 |
| Cwm, LLC | 0.00% | Reduce -99.1% | 6 | $0 |
| Covestor Ltd | 0.00% | Reduce -4.6% | 62 | $0 |
"% of holder's portfolio" is NGM's weight in each manager's 13F, not the share of NGM Biopharmaceuticals Inc. the manager owns.